Dr. Emem Inyang Adolf-Ubokudom, MD

Dr. Adolf-Ubokudom practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Dr. Adolf-Ubokudom's NPI, 1861780603, was assigned on July 14, 2011. Dr. Adolf-Ubokudom holds Massachusetts license 277137.

Dr. Adolf-Ubokudom's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Dr. Adolf-Ubokudom's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. The medical group on file is Cambridge Health Alliance. Dr. Adolf-Ubokudom's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adolf-Ubokudom practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Adolf-Ubokudom's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Adolf-Ubokudom's licenses on file in 2 states: Massachusetts and Illinois.

CMS data shows 130 Medicare services from Dr. Adolf-Ubokudom across 3 procedure codes in 2024, all of them office visits, for 54 Medicare patients. Medicare paid $9,817 for them.

CMS counts 54 Medicare patients who saw Dr. Adolf-Ubokudom in 2024. The largest group is 65 to 74, with 26 patients. 74% of them have arthritis, and 59% have high blood pressure. 44% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Adolf-Ubokudom's median patient age at 55, with 70% women.

In 2024, Dr. Adolf-Ubokudom wrote 583 Medicare Part D claims for 149 patients. 62% of them were for generic drugs. CMS names the drug for 429 of them, across 14 drugs with 11 or more claims each, at $864,980 in total drug cost. In 2023, CMS named 407 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Adolf-Ubokudom for performance year 2024, reported as part of a group. Dr. Adolf-Ubokudom accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Adolf-Ubokudom as offering telehealth.

CMS Open Payments shows 136 general payments to Dr. Adolf-Ubokudom from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Janssen Pharmaceuticals, Inc paid the most, $46,516.